2.6.3Segment

Nutrition & Weight Management

Weight management programs, nutrition counseling practices, and medically supervised dietary intervention providers.

4
Verticals

Overview

Nutrition & Weight Management covers weight-loss programs, nutrition counseling, and medically supervised dietary intervention. The segment has been upended by GLP-1 weight-loss drugs (Ozempic, Wegovy and peers), which drove the collapse of legacy programs — Jenny Craig shut down, and Weight Watchers' traditional model fell sharply — and a pivot toward medical and GLP-1-enabled weight management.

Demand for weight management is enormous and growing, but the delivery model is being rewritten in real time, with telehealth and pharmacy-enabled GLP-1 programs displacing diet-and-coaching businesses. The winners are repositioning around medical weight loss rather than traditional dieting.

Market snapshot

Market size
~$2.4B
Growth
~6.0%CAGR (2017–22, nominal)
Companies
~1,383 firms
Firms by employee count

95.4% of firms have fewer than 20 employees: 1,320 micro-businesses, below most mandates.

The investable universe63 firms with 20+ employees
20–99
5079%
100–499
914%
500+
46%

figures predate the full GLP-1 disruption now reshaping the segment.

NAICS 812191. U.S. Census Bureau — 2022 Statistics of U.S. Businesses; U.S. Census Bureau — 2022 Economic Census.

Business model & economics

Revenue model

Program, coaching, and increasingly medical/GLP-1 fees

Key economics

Revenue per firm
$1,724,874
Revenue per employee
$173,693
Employees per firm
9.5
Recurring revenue
Moderate

subscription programs, but high churn

EBITDA margin
10–20%
Capex intensity
Low

Characteristics

  • Product- and franchise-led — payroll is only 15% of revenue; the cost base is meal products and program systems, not labor
  • Thin strategic-buyer pool — only 4 firms exceed 500 employees; exits skew sponsor-to-sponsor
  • GLP-1 drugs are rewriting the weight-management model.
  • Legacy diet-and-coaching programs collapsed or pivoted.
  • Winners are repositioning around medical weight loss.

NAICS 812191. U.S. Census Bureau — 2022 Statistics of U.S. Businesses; U.S. Census Bureau — 2022 Economic Census.

M&A deal context

Deal activityModerate

Who’s acquiring

  • Telehealth & medical weight-loss platforms
  • Pharmacy & GLP-1-enabled providers
  • Distressed-asset acquirers

What’s driving deals

  • GLP-1 disruption forcing model change and distress.
  • Telehealth and pharmacy-enabled weight management scaling.
  • Pivot from traditional dieting to medical weight loss.

Verticals in this segment

Find Nutrition & Weight Management acquisition targets

Search Acquisera’s index for companies classified under Nutrition & Weight Management (2.6.3) and build a targeted deal pipeline.

Search companies